Daniela Anne Carusi, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Placenta Previa | 18 | 2024 | 117 | 6.790 |
Why?
|
Placenta Accreta | 22 | 2024 | 225 | 6.650 |
Why?
|
Cesarean Section | 24 | 2024 | 1365 | 3.190 |
Why?
|
Delivery, Obstetric | 10 | 2022 | 906 | 1.880 |
Why?
|
Uterine Rupture | 3 | 2022 | 72 | 1.410 |
Why?
|
Labor Presentation | 3 | 2018 | 53 | 1.170 |
Why?
|
Pregnancy, Ectopic | 2 | 2018 | 141 | 1.140 |
Why?
|
Twins | 2 | 2018 | 339 | 1.120 |
Why?
|
Anesthesia, Obstetrical | 2 | 2018 | 235 | 1.060 |
Why?
|
Pregnancy | 50 | 2024 | 29144 | 1.050 |
Why?
|
Postpartum Hemorrhage | 6 | 2022 | 258 | 1.020 |
Why?
|
Hysterotomy | 2 | 2021 | 22 | 0.900 |
Why?
|
Hysterectomy | 9 | 2024 | 927 | 0.840 |
Why?
|
Placenta, Retained | 2 | 2018 | 21 | 0.800 |
Why?
|
Anesthesiology | 3 | 2019 | 1060 | 0.730 |
Why?
|
Parity | 3 | 2017 | 929 | 0.690 |
Why?
|
Reproductive Techniques, Assisted | 3 | 2022 | 482 | 0.680 |
Why?
|
Embryo Transfer | 3 | 2019 | 510 | 0.640 |
Why?
|
Obstetric Labor Complications | 2 | 2019 | 238 | 0.640 |
Why?
|
Ultrasonography, Prenatal | 4 | 2023 | 1695 | 0.590 |
Why?
|
Fertilization in Vitro | 6 | 2022 | 1284 | 0.590 |
Why?
|
Endometriosis | 2 | 2022 | 839 | 0.580 |
Why?
|
Maternal Age | 1 | 2018 | 802 | 0.530 |
Why?
|
Anesthesia, Conduction | 1 | 2018 | 238 | 0.520 |
Why?
|
Placenta | 11 | 2024 | 1699 | 0.520 |
Why?
|
Patient Selection | 2 | 2017 | 4216 | 0.510 |
Why?
|
Intention | 1 | 2017 | 342 | 0.480 |
Why?
|
Parturition | 1 | 2017 | 441 | 0.460 |
Why?
|
Early Diagnosis | 1 | 2018 | 1184 | 0.460 |
Why?
|
Trial of Labor | 3 | 2021 | 80 | 0.460 |
Why?
|
Pregnancy Outcome | 8 | 2022 | 2795 | 0.450 |
Why?
|
Pregnancy Complications | 3 | 2019 | 2861 | 0.450 |
Why?
|
Retrospective Studies | 32 | 2024 | 77460 | 0.450 |
Why?
|
Premature Birth | 4 | 2022 | 1721 | 0.430 |
Why?
|
Cryopreservation | 2 | 2019 | 670 | 0.390 |
Why?
|
Cicatrix | 2 | 2024 | 764 | 0.380 |
Why?
|
Gestational Age | 6 | 2022 | 3493 | 0.370 |
Why?
|
Catheter-Related Infections | 1 | 2013 | 252 | 0.360 |
Why?
|
Catheterization, Peripheral | 1 | 2013 | 345 | 0.350 |
Why?
|
Female | 51 | 2024 | 380193 | 0.330 |
Why?
|
Catheterization, Central Venous | 1 | 2013 | 514 | 0.320 |
Why?
|
Uterus | 3 | 2024 | 711 | 0.310 |
Why?
|
Uterine Hemorrhage | 2 | 2020 | 255 | 0.290 |
Why?
|
Risk Factors | 17 | 2023 | 72296 | 0.290 |
Why?
|
Uterine Artery Embolization | 3 | 2017 | 62 | 0.290 |
Why?
|
Abortion, Spontaneous | 3 | 2019 | 544 | 0.270 |
Why?
|
Ultrasonography | 1 | 2018 | 5984 | 0.260 |
Why?
|
Blood Transfusion | 3 | 2022 | 1301 | 0.230 |
Why?
|
Maternal Health Services | 2 | 2019 | 455 | 0.230 |
Why?
|
Humans | 53 | 2024 | 744366 | 0.230 |
Why?
|
Gynatresia | 1 | 2022 | 15 | 0.220 |
Why?
|
Pregnancy Trimester, First | 2 | 2017 | 853 | 0.210 |
Why?
|
Abortifacient Agents, Nonsteroidal | 2 | 2017 | 62 | 0.200 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2017 | 500 | 0.190 |
Why?
|
Adult | 22 | 2021 | 214052 | 0.190 |
Why?
|
Thrombelastography | 1 | 2022 | 164 | 0.190 |
Why?
|
Cervix Uteri | 2 | 2015 | 590 | 0.190 |
Why?
|
Venous Thromboembolism | 1 | 2013 | 1671 | 0.190 |
Why?
|
Odds Ratio | 3 | 2017 | 9849 | 0.180 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2018 | 73 | 0.170 |
Why?
|
Home Childbirth | 1 | 2019 | 51 | 0.170 |
Why?
|
Live Birth | 3 | 2019 | 512 | 0.160 |
Why?
|
Mandatory Testing | 1 | 1998 | 23 | 0.160 |
Why?
|
Blood Loss, Surgical | 2 | 2020 | 662 | 0.160 |
Why?
|
Dilatation and Curettage | 1 | 2017 | 56 | 0.150 |
Why?
|
Perinatal Care | 1 | 2019 | 227 | 0.150 |
Why?
|
Vaginal Birth after Cesarean | 1 | 2017 | 62 | 0.150 |
Why?
|
Blastocyst | 1 | 2019 | 424 | 0.140 |
Why?
|
Hyponatremia | 1 | 2019 | 298 | 0.140 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2022 | 489 | 0.140 |
Why?
|
Pregnancy Rate | 2 | 2019 | 643 | 0.140 |
Why?
|
Morbidity | 2 | 2023 | 1768 | 0.140 |
Why?
|
Boston | 3 | 2019 | 9312 | 0.130 |
Why?
|
Prenatal Diagnosis | 2 | 2020 | 1236 | 0.130 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2018 | 337 | 0.130 |
Why?
|
Erythrocyte Transfusion | 1 | 2020 | 565 | 0.130 |
Why?
|
Treatment Refusal | 1 | 1998 | 421 | 0.120 |
Why?
|
Young Adult | 5 | 2020 | 56429 | 0.120 |
Why?
|
Labor, Induced | 1 | 2015 | 146 | 0.120 |
Why?
|
Sperm Injections, Intracytoplasmic | 1 | 2015 | 160 | 0.120 |
Why?
|
Lacerations | 1 | 2015 | 144 | 0.120 |
Why?
|
Japan | 1 | 2018 | 1360 | 0.120 |
Why?
|
Phlebitis | 1 | 2013 | 31 | 0.120 |
Why?
|
Methotrexate | 2 | 2017 | 1728 | 0.110 |
Why?
|
Logistic Models | 3 | 2018 | 13409 | 0.110 |
Why?
|
Incidence | 4 | 2022 | 20952 | 0.110 |
Why?
|
Diabetes, Gestational | 1 | 2022 | 1184 | 0.110 |
Why?
|
Varicose Veins | 1 | 2014 | 154 | 0.100 |
Why?
|
Parenteral Nutrition, Total | 1 | 2013 | 302 | 0.100 |
Why?
|
Patient Transfer | 1 | 2019 | 762 | 0.100 |
Why?
|
Endometrium | 1 | 2015 | 424 | 0.100 |
Why?
|
Anesthesia, General | 1 | 2018 | 1171 | 0.100 |
Why?
|
Cohort Studies | 5 | 2022 | 40559 | 0.100 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 1998 | 1320 | 0.090 |
Why?
|
Area Under Curve | 1 | 2015 | 1655 | 0.090 |
Why?
|
Control Groups | 2 | 2020 | 105 | 0.090 |
Why?
|
Program Evaluation | 1 | 2018 | 2488 | 0.090 |
Why?
|
Infant, Newborn | 6 | 2022 | 25628 | 0.080 |
Why?
|
Treatment Outcome | 5 | 2020 | 63107 | 0.080 |
Why?
|
Birth Weight | 3 | 2022 | 2069 | 0.080 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3508 | 0.080 |
Why?
|
Hemorrhage | 1 | 2020 | 3461 | 0.080 |
Why?
|
Estradiol | 1 | 2015 | 2020 | 0.070 |
Why?
|
ROC Curve | 1 | 2015 | 3528 | 0.070 |
Why?
|
Middle Aged | 6 | 2020 | 213390 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1956 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1998 | 2026 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2018 | 15297 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2023 | 21748 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7282 | 0.060 |
Why?
|
Developmental Disabilities | 1 | 2013 | 1456 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2760 | 0.060 |
Why?
|
Hospitals | 1 | 2017 | 3954 | 0.060 |
Why?
|
Oxytocics | 1 | 2003 | 68 | 0.060 |
Why?
|
Quality Improvement | 1 | 2018 | 3749 | 0.060 |
Why?
|
Laparoscopy | 1 | 2015 | 2150 | 0.050 |
Why?
|
Misoprostol | 1 | 2003 | 95 | 0.050 |
Why?
|
Recurrence | 1 | 2013 | 8340 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12244 | 0.050 |
Why?
|
Risk Assessment | 2 | 2019 | 23336 | 0.050 |
Why?
|
Pregnancy Trimester, Third | 1 | 2023 | 571 | 0.050 |
Why?
|
Culture Media | 1 | 2022 | 909 | 0.040 |
Why?
|
Databases, Factual | 1 | 2015 | 7730 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4687 | 0.040 |
Why?
|
Embryo Culture Techniques | 1 | 2019 | 80 | 0.040 |
Why?
|
Delphi Technique | 2 | 2019 | 779 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15078 | 0.040 |
Why?
|
Hematocrit | 1 | 2020 | 636 | 0.040 |
Why?
|
Age Factors | 1 | 2015 | 18373 | 0.040 |
Why?
|
Maternal Mortality | 1 | 2020 | 310 | 0.040 |
Why?
|
Oocyte Retrieval | 1 | 2018 | 161 | 0.040 |
Why?
|
California | 1 | 2021 | 1402 | 0.040 |
Why?
|
Time Factors | 1 | 2018 | 40075 | 0.040 |
Why?
|
Uterine Artery | 1 | 2015 | 36 | 0.030 |
Why?
|
Hypertension | 1 | 2015 | 8479 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 7182 | 0.030 |
Why?
|
Balloon Occlusion | 1 | 2015 | 126 | 0.030 |
Why?
|
Hysteroscopy | 1 | 2015 | 102 | 0.030 |
Why?
|
Ligation | 1 | 2015 | 453 | 0.030 |
Why?
|
Myometrium | 1 | 2015 | 181 | 0.030 |
Why?
|
Infant, Premature | 1 | 2022 | 2045 | 0.030 |
Why?
|
Mothers | 1 | 2023 | 2165 | 0.030 |
Why?
|
Weight Gain | 1 | 2022 | 2293 | 0.030 |
Why?
|
HIV Infections | 1 | 1998 | 16715 | 0.030 |
Why?
|
Postoperative Hemorrhage | 1 | 2015 | 412 | 0.020 |
Why?
|
Pregnancy Trimester, Second | 1 | 2014 | 732 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 2960 | 0.020 |
Why?
|
Perception | 1 | 1997 | 1198 | 0.020 |
Why?
|
Functional Laterality | 1 | 1997 | 2290 | 0.020 |
Why?
|
Massachusetts | 1 | 2022 | 8662 | 0.020 |
Why?
|
Abortion, Induced | 1 | 2014 | 458 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 25039 | 0.020 |
Why?
|
Adolescent | 1 | 2015 | 85779 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5953 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9688 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19905 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1994 | 6036 | 0.020 |
Why?
|
Cervical Ripening | 1 | 2003 | 18 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2015 | 3799 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12961 | 0.010 |
Why?
|
Abortion, Legal | 1 | 2003 | 116 | 0.010 |
Why?
|
Male | 3 | 2022 | 350115 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 1994 | 6994 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2003 | 1584 | 0.010 |
Why?
|
Child | 1 | 2024 | 77709 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 53290 | 0.010 |
Why?
|
United States | 2 | 2017 | 69872 | 0.010 |
Why?
|
Women's Health | 1 | 2003 | 2034 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 1994 | 8038 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1994 | 980 | 0.010 |
Why?
|
Corpus Callosum | 1 | 1997 | 737 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2003 | 3611 | 0.010 |
Why?
|
Visual Fields | 1 | 1997 | 1047 | 0.010 |
Why?
|
Observer Variation | 1 | 1994 | 2593 | 0.010 |
Why?
|
Epilepsy | 1 | 1997 | 3310 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 1994 | 14723 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 1994 | 57776 | 0.000 |
Why?
|
Aged | 1 | 1994 | 163288 | 0.000 |
Why?
|